Abstract
Primary sclerosing cholangitis is characterized by progressive fibrosing inflammation of the bile ducts, leading to their obliteration, which results in cholestasis and, finally, cirrhosis of the liver. Over time, the majority of patients with advanced disease develop dominant stenoses of major bile ducts. Ursodeoxycholic acid (UDCA) treatment does not prevent the development of such stenoses. Endoscopic measures allow the opening of short- and long-segment stenoses of the common bile duct and also of short segment stenoses of the hepatic ducts. In patients treated by early endoscopic dilatation of dominant stenoses, as well as with UDCA, survival may be significantly improved (compared with the predicted survival).
Similar content being viewed by others
References
Chapman, R.W., Arborgh, B.A., Rhodes, J.M., et al. (1980), Gut 21, 870–877.
Wiesner, R.H., Grambsch, P.M., Dickson, E.R., et al. (1989), Hepatology 10, 430–436.
Farrant, M.J., Hayllar, K.M., Wilkinson, M.L., et al. (1991), Gastroenterology 100, 1710–1717.
Broome, U., Olson, R., Lööf, L., et al. (1996), Gut 38, 610–615.
Fulcher, A.S., Turner, M.A., Franklin, K.J., et al. (2000), Radiology 215, 71–80.
Angulo, P., Pearce, D.H., Johnson, C.D., et al. (2000), J Hepatol 33, 520–527.
Textor, H.J., Flacke, S., Pauleit, D., et al. (2002), Endoscopy 34, 984–990.
Stiehl, A., Rudolph, G., Sauer, P., et al. (1997), J Hepatol 26, 560–566.
Grijm, R., Huibregtse, K., Bartelsman, J., et al. (1986), Dig Dis Sci 31, 792–798.
Johnson, G.K., Geenen, J.E., Venu, R.P., and Hogan, W.J. (1987), Gastrointest Endosc 33, 9–12.
Cotton, P.B. and Nickl, N. (1991), Sem Liv Dis 11, 40–48.
Craig, P.I. and Hatfield, R.W. (1992), Eur J Gastroentrol Hepatol 4, 284–287.
Gaing, A.A., Geders, J.M., Cohen, S.A., and Siegel, J.H. (1993), Am J Gastroenterol 88, 2000–2008.
Lee, J.G., Schutz, S.M., England, R.E., Leung, J.W., and Cotton, P.B. (1995), Hepatology 21, 661–667.
van Milligen, A.W.M., van Bracht, J., Rauws, E.A.J., et al. (1996), Gastrointest Endosc 44, 293–299.
Wagner, S., Gebel, M., Meier, P., et al. (1996), Endoscopy 28, 546–551.
Petersen, K.M., Angulo, P., Baron, T.H., et al. (2001), Am J Gastroenterol 96, 1059–1066.
Baluyut, A.R., Sherman, S., Lehman, G.A., Hoen, H., and Chalasani, N. (2001), Gastrointest Endosc 53, 308–312.
Stiehl, A., Rudolph, G., Klöters-Plachky, P., et al. (2002), J Hepatol 36, 151–156.
Olson, R., Björnsson, E., Bäckman, L., et al. (1998), J Hepatol 28, 426–432.
Hammel, P., Couvelard, A., O’Toole, D., et al. (2001), N Engl J Med 344, 418–423.
May, G.R., Bender, C.E., LaRusso, N.J., and Wiesner, R.H. (1985), AJR 145, 1470.
Hulcrantz, R., Olsson, R., Danielsson, A., et al. (1999), J Hepatol 30, 660–673.
Ponsioen, C.Y., Vrouenraets, S.M., van Milligen de Wit, A.W., et al. (1999), Endoscopy 31, 305–309.
Keiding, S., Hansen, S.B., Rasmussen, H.H., et al. (1998), Hepatology 28, 700–706.
Kluge, R., Schmidt, F., Caca, K., et al. (2001), Hepatology 33, 1029–1035.
Nashan, B., Schlitt, H.J., Tusch, G., et al. (1996), Hepatology 23, 1105–1111.
Lindor, K.D. and the Mayo PSC/UDCA Study Grou (1997), N Engl J Med 336, 691–695.
Beuers, U., Spengler, U., Kruis, W., et al. (1992), Hepatology 16, 707–714.
Stiehl, A., Walker, S., Stiehl, L., et al. (1994), J Hepatol 20, 57–64.
Mitchell, S.A., Bansi, D., Hunt, N., et al. (2001), Gastroenterology 121, 900–907.
Harnois, D.M., Angulo, P., Jorgensen, R.A., LaRusso, N.F., and Lindor, K.D. (2001), Am J Gastroenterol 96, 1558–1562.
Harrison, R.F., Davies, M.H., Neuberger, J., et al. (1994) Hepatology 20, 356–361.
Graziadei, I.W., Wiesner, R.H., Batts, K.P., et al. (1999), Hepatology 29, 1050–1056.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stiehl, A., Rost, D. Endoscopic treatment of dominant stenoses in patients with primary sclerosing cholangitis. Clinic Rev Allerg Immunol 28, 159–165 (2005). https://doi.org/10.1385/CRIAI:28:2:159
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:28:2:159